Cephalon
Navigation Links
Cephalon in Medical News
TREANDA Receives Second Indication this Year; Data Demonstrate High,
Durable Response Rates for Patients with indolent NHL Who Have Progressed
Following a Rituximab-Containing Regimen
FRAZER, Pa., Nov. 3 /PRNewswire-FirstCall/ -- Cephalon, Inc., (Nasdaq:
CEPH) today announced that the U.S. F...
NEW YORK, Sept. 17 /PRNewswire/ -- ExL Pharma is pleased to announce three Clinical Data Focused conferences which cover many of the leading issues that are impacting the pharmaceutical industry today. These events offer educational and networking opportunities for Clinical, R&D, Regulatory an...
...otic catastrophe (a non-apoptotic pathway). cephalon holds exclusive rights to market and develop TREAN...ber of the Fortune 1000 and the S&P 500 Index, cephalon currently employs approximately 3,000 people in th...Utah, and suburban Minneapolis, Minnesota. cephalon has a growing presence in Europe, the Middle East ...
...t Cephalon. "Based on the findings of this study, cephalon will submit a supplemental New Drug Application to...ber of the Fortune 1000 and the S&P 500 Index, cephalon currently employs approximately 3,000 people in th..., Utah, and suburban Minneapolis, Minnesota. cephalon has a growing presence in Europe, the Middle East ...
...lso known as shift work disorder, and narcolepsy. cephalon has finalized the commercialization plans for NUVI...s Programs As part of the launch of NUVIGIL, cephalon is introducing several new programs designed to ex...st insured patients with co-pay costs for NUVIGIL, cephalon will offer the NUVIGIL Prescription Savings Progra...
inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc.
SOMERSET, N.J., March 6 /PRNewswire-FirstCall/ -- inVentiv Selling Solutions, a division of inVentiv Health (Nasdaq: VTIV ) and the industry leader in outsourced sales teams to the pharmaceutical industry, announced today that it has signed a contract with Cephalon Inc. to provide a sales tea...NEW YORK, Sept. 17 /PRNewswire/ -- ExL Pharma is pleased to announce three Clinical Data Focused conferences which cover many of the leading issues that are impacting the pharmaceutical industry today. These events offer educational and networking opportunities for Clinical, R&D, Regulatory an...
Ohio Sales Rep's Information Launched Massive Government Investigation of Cephalon
Unique off-label marketing case results in $425M settlement WASHINGTON, Sept. 29 /PRNewswire/ -- The government's investigation into Cephalon Inc.'s illegal marketing practices that culminated in today's $425,000,000 settlement and guilty plea by the pharmaceutical company began in Janua...Provigil Patent Extension Accorded To Cephalon
Cephalon has been accorded a further six months of patent extension by the FDA for its pediatric sleep disorder treatment medication//, Provigil. Cephlaon had complied with the terms of an explicit written request that entailed the provision of clinical studies data after studying the effect......otic catastrophe (a non-apoptotic pathway). cephalon holds exclusive rights to market and develop TREAN...ber of the Fortune 1000 and the S&P 500 Index, cephalon currently employs approximately 3,000 people in th...Utah, and suburban Minneapolis, Minnesota. cephalon has a growing presence in Europe, the Middle East ...
New Report Just Published: World Multiple Myeloma Therapeutics Market Report
...Praecis Pharmaceuticals II-54 Biotest Acquires ImmunoGen Anticancer Technology Rights II-54 Hana Signs Licensing Agreement with Inex II-54 cephalon Acquires Zeneus II-54 5. Focus on Select Players II-55 Amgen Inc (USA) II-55 Avalon Pharmaceuticals, Inc. (USA) II-55 Bristol-Myers S......t Cephalon. "Based on the findings of this study, cephalon will submit a supplemental New Drug Application to...ber of the Fortune 1000 and the S&P 500 Index, cephalon currently employs approximately 3,000 people in th..., Utah, and suburban Minneapolis, Minnesota. cephalon has a growing presence in Europe, the Middle East ...
ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
...He is the chief executive officer and chairman of the board of directors of cephalon Inc., an international biopharmaceutical company in Chester County, Pennsylvania. Dr. Baldino founded cephalon in 1987 and has served as chief executive officer and director since its in......lso known as shift work disorder, and narcolepsy. cephalon has finalized the commercialization plans for NUVI...s Programs As part of the launch of NUVIGIL, cephalon is introducing several new programs designed to ex...st insured patients with co-pay costs for NUVIGIL, cephalon will offer the NUVIGIL Prescription Savings Progra...
Cephalon in Medical Technology
Study Reports 92 Percent Response Rate to Combination Treatment
FRAZER, Pa., July 15 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq:
CEPH) announced today that in a phase 2 study published online today in the
Journal of Clinical Oncology, 92 percent of patients with relapsed indolent
B-c...
...ber of the Fortune 1000 and the S&P 500 Index, cephalon currently employs approximately 3,000 people in th..., Utah, and suburban Minneapolis, Minnesota. cephalon has a growing presence in Europe, the Middle East and Africa. The cephalon European headquarters and pre-clinical development...
...hrough pain. In its letter, the FDA requested that cephalon implement and demonstrate the effectiveness of pro.../www.fentora.com ). The FENTORA sNDA, submitted by cephalon in November 2007, is based on data from three rand...ll as more specific risks and uncertainties facing cephalon such as those set forth in its reports on Form 8-K...
...TREANDA for the treatment of patients with CLL and cephalon expects a review decision from FDA by the end of M...REANDA for CLL in August 2007, which would entitle cephalon to a seven-year period of marketing exclusivity fo...tients with relapsed indolent and mantle cell NHL. cephalon plans to submit an NDA for TREANDA by the end of 2...
... a New Drug Application (NDA). In September 2007, cephalon submitted an NDA requesting approval of TREANDA fo...ay be attributable to its unique chemical design. cephalon holds exclusive rights to market and develop TREAN... HCl in Japan and selected Asian countries. About cephalon Oncology ...
...ber of the Fortune 1000 and the S&P 500 Index, cephalon currently employs approximately 3,000 people in th..., Utah, and suburban Minneapolis, Minnesota. cephalon has a growing presence in Europe, the Middle East and Africa. The cephalon European headquarters and pre-clinical development...
Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
...reatment options," said Frank Baldino, Jr., Ph.D., cephalon founder, chairman and CEO. "Patients with life-threatening diseases need companies like cephalon to make that investment and take that risk if we a...he overall cost of healthcare." Developed by cephalon scientists, lestaurtinib is a potent inhibitor of ...Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder
...ift work, time zone changes and medications. cephalon is preparing to launch NUVIGIL, the longer-lasting...ber of the Fortune 1000 and the S&P 500 Index, cephalon currently employs approximately 3,000 people in th..., Utah, and suburban Minneapolis, Minnesota. cephalon has a growing presence in Europe, the Middle East ...Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
...bo group included restlessness and anxiety. cephalon is preparing to launch NUVIGIL, the longer-lasting...ber of the Fortune 1000 and the S&P 500 Index, cephalon currently employs approximately 3,000 people in th..., Utah, and suburban Minneapolis, Minnesota. cephalon has a growing presence in Europe, the Middle East ...Cephalon Signs Option Agreement to Acquire Ception Therapeutics
...t the companies have signed an agreement providing cephalon with an option to purchase all outstanding capital...Ception. Under the terms of the option agreement, cephalon will pay Ception a $100 million upfront option pay...TNF (tumor necrosis factor) receptor agents. cephalon may exercise its option at any time prior to expir......hrough pain. In its letter, the FDA requested that cephalon implement and demonstrate the effectiveness of pro.../www.fentora.com ). The FENTORA sNDA, submitted by cephalon in November 2007, is based on data from three rand...ll as more specific risks and uncertainties facing cephalon such as those set forth in its reports on Form 8-K...
TREANDA Demonstrates Substantial Efficacy in Patients with Relapsed Indolent Non-Hodgkin's Lymphoma
...nical endpoints and/or data analysis. In addition, cephalon has completed a phase 2 study with TREANDA in comb...tients with relapsed indolent and mantle cell NHL. cephalon plans to submit a new drug application (NDA) for T...ing treatment with rituximab. In September 2007, cephalon submitted an NDA requesting approval of TREANDA fo......TREANDA for the treatment of patients with CLL and cephalon expects a review decision from FDA by the end of M...REANDA for CLL in August 2007, which would entitle cephalon to a seven-year period of marketing exclusivity fo...tients with relapsed indolent and mantle cell NHL. cephalon plans to submit an NDA for TREANDA by the end of 2...
... a New Drug Application (NDA). In September 2007, cephalon submitted an NDA requesting approval of TREANDA fo...ay be attributable to its unique chemical design. cephalon holds exclusive rights to market and develop TREAN... HCl in Japan and selected Asian countries. About cephalon Oncology ...
Cephalon in Biological News
Researchers seek to design first treatment for neuroAIDS
...dical Center, had served as an auditor of Cephalon's PRECEPT trial, where CEP-1347 was tested as a treatment for Parkinson's disease. He proposed that cephalon make the drug available for the study of the drug's effect on neuroAIDs. CEP-1347 has already proven capable of reversing the neurotoxic effects of HI...Cephalon in Biological Technology
$425 Million Cephalon Civil Settlement and Criminal Fine; In America's Largest
Biotechnology Medicaid Fraud Case; Qui Tam Whistleblower Attorney Brian P. Kenney, Esq. Filed First Complaint With Client's Off-Label Marketing Allegations In 2003; Additional Complaints Were Filed; $375 Million Civil Settlement, $50 Million Corporate Criminal Fine Today PHILADELPHIA,...Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit
...n/prnh/20090731/PH54744 ) "Since joining cephalon two years ago, Craig has clearly demonstrated an a... and vision will support the dynamic growth of the cephalon Oncology business and allow us to continue to brin...patients battling cancer." Phillips joined cephalon in 2007 as Senior Group Director of Sales, Nationa......% convertible senior subordinated notes due 2014. cephalon has also granted the underwriters a 30-day option,...rincipal amount plus accrued and unpaid interest. cephalon may not redeem the notes prior to the maturity dat...e additional notes or shares of common stock. cephalon intends to use a portion of the net proceeds of th...
...due 2014 through two concurrent public offerings. cephalon will grant the underwriters a 30-day option, solel...of pricing of the offering by negotiations between cephalon and the underwriters. The notes will be subordina... upon the consummation of the other offering. cephalon intends to use a portion of the net proceeds of th...
...'s Trade Alerts include: Forest Laboratories Inc. (NYSE: FRX ), Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA ), Allergan Inc. (NYSE: AGN ), cephalon Inc. (Nasdaq: CEPH ), Vertex Pharmaceuticals Inc. (Nasdaq: VRTX ) and Adolor Corp. (Nasdaq: ADLR ). Join the fastest growing investment c...
Cephalon's New Product Launches Pace Record 2008 Sales
...elves coupled with our internal pipeline positions cephalon favorably for future growth." The company i...e per common share guidance of $6.50 - $6.60. cephalon is introducing first quarter 2009 sales guidance o...ors for one week after the call. About cephalon , Inc. Founded in 1987, Cephalon, Inc. is a...... this role, Dr. Duddu will lead all aspects of the cephalon drug delivery business at CIMA, its wholly owned d...In his new role, Dr. Duddu will be a member of the cephalon Technical Operations leadership team and will repo..., OraVescent(R), and OTC(R) (oral transmuscosal). cephalon currently manufactures the following products in t...
Cephalon Exercises Option to License Worldwide Rights to ImmuPharma Product, Lupuzor
...interim results of the ImmuPharma Phase IIb study. cephalon will assume all expenses for Phase III studies, re... of the deal last year. In exercising its option, cephalon will pay ImmuPharma a one-time license fee of $30 ...y diseases." "The exercise of the option by cephalon validates the analysis ImmuPharma made of the inte......X until 2025 and we intend to work diligently with cephalon to protect this important product," said Manya S. ...oprietary drug delivery formulation technologies. cephalon is the exclusive licensee and marketer of AMRIX in...urrent with the patent protection described above, cephalon has a three-year period of marketing exclusivity p...
Standard & Poor's Announces Changes to U.S. Indices
...th in the index. -- S&P MidCap 400 constituent cephalon Inc. (Nasdaq: CEPH ) will be added to the S&...Mariner Energy Inc. (NYSE: ME ) will replace cephalon Inc. in the S&P MidCap 400, after the close of trading on Friday, November 14. cephalon is taking the place of General Growth Propert...Cephalon in Biological Definition
...gy companies, ranked by 2003 sales, are:
Amgen
Genentech
Serono
Biogen Idec
Chiron
Genzyme
MedImmune
Gilead Sciences
cephalon
Millennium Pharmaceuticals
Biotechnology in fiction
Star Trek
The Breen use starships with organic technology. The starship US...
Cephalon in Biological Dictionary
...ct the bones of the skull. ... Feeling the cranial sutures and fontanelles is ... The facial sutures of Asaphiscus run from the anterior of the cephalon to the ... What are facial sutures ? ... Facial sutures once played a primary role in ... Sutures , or stitches, are the most commonly used met...
Other TagsPhencyclidineOther Contentsgastrectomysuctionsuctionsuctionsuctionsuctiongastrinomagastritisgastritisgastroenterologygastrointestinalgastrointestinalgastrointestinalgastrointestinalgastrointestinalgastrointestinalgastrointestinalgastroesophagealgastroesophagealgastroesophagealgeneralgeneralgeneralgeneralgeneralgeneralgeneralgeneralgeneralgeneral
AggRAMSonoclotGundrySureCathSpeediCathPerfluoronEpocratesPatientKeeperSTELLARADuranMultifrequencyAtheNAGalileoPhencyclidine
(Date:11/9/2009)...Study didn,t answer question of why this is so, ho...ws) -- After a lumpectomy, women with very dense b...the affected breast, a new study shows. , Breas...d risk of developing breast cancer, and experts ha...ssociated with an increased risk of cancer recurre...
(Date:11/9/2009)...,, CAMBRIDGE, Mass., Nov. 9 A...nd capabilities in delivering emergency management...ly awarded contracts to support the work of the Fe...of Regional Operations, the National Commission on...litan Area Transit Authority (WMATA). The value o...
(Date:11/9/2009)...,, WASHINGTON, Nov. 9 /PRNewswire-USNewswire/ -...PA), representing more than 75,000 clinically prac...e United States, applauds the U.S. House of Repres...orm bill, H.R. 3962, the Affordable Health Care fo...that this reform bill will ultimately lower the co...
(Date:11/9/2009)... This release is available in French . , ,... came in twos: male and female. In human bodies tr...molecules from which they are composed. Yet these...tinguishable clusters. Because these complex cell ...ientists have long searched for ways to splice cel...
(Date:11/9/2009)... As many as 10 million people around the world su...niversity in Frankfurt and his coauthors discuss c...cial lens in the current issue of Deutsches rzteb...[43]: 695�). , Blindness is usually due t...e than 600,000 cataract operations are performed e...
Breaking Medicine News(10 mins):Health News:Dense Breasts Raise Risk of Cancer Recurrence 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 3Health News:Abt Associates Expands Emergency Management Support Services To the Federal Government and Washington Metropolitan Area Transit Authority 2Health News:American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill 2[0] Dense Breasts Raise Risk of Cancer Recurrence[0] Abt Associates Expands Emergency Management Support Services To the Federal Government and Washington Metropolitan Area Transit Authority[0] American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill[0] Researchers show how to divide and conquer 'social network' of cells[0] The world's most common operation
(Date:11/9/2009)... inspired a 3.2m, three-year research project that...ecurity, energy and the environment. The Universit...inetiQ have just signed a collaborative contract t... physical sciences research. , Over the next th... of Exeter and QinetiQ will work together to devel...
(Date:11/9/2009)...eaders from around the world will gather in Boston...r Targets and Cancer Therapeutics International Co...ation on important cancer therapies in development...t effectively we need a greater understanding of t...l," said Lewis Cantley, Ph.D., director of the can...
(Date:11/8/2009)...S WITH INTELLECTUAL DISABILITIES: AN OPPORTUNITY F...y involving adults with intellectual disabilities ...lth knowledge after taking a semi-weekly class for...ly accepted term for mental retardation, have slig...and preventable chronic diseases compared to the g...
Breaking Biology News(10 mins):£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Nevada Drug Card and Las Vegas Chamber Offer Rx Assistance 52973 1Report Shows New York City Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases 52970 1Report Shows New York City Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases 52970 2Report Shows New York City Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases 52970 3Report Shows New York City Companies Playing Key Role In Development of New Medicines for Wide Range of Diseases 52970 4New drug for children with high risk leukemia 52965 1New drug for children with high risk leukemia 52965 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |